ZA972757B - Porphyromonas gingivalis antigents for the diagnosis and treatment of periodontitis. - Google Patents

Porphyromonas gingivalis antigents for the diagnosis and treatment of periodontitis.

Info

Publication number
ZA972757B
ZA972757B ZA9702757A ZA972757A ZA972757B ZA 972757 B ZA972757 B ZA 972757B ZA 9702757 A ZA9702757 A ZA 9702757A ZA 972757 A ZA972757 A ZA 972757A ZA 972757 B ZA972757 B ZA 972757B
Authority
ZA
South Africa
Prior art keywords
antigen
gingivalis
amino acid
acid sequence
internal amino
Prior art date
Application number
ZA9702757A
Other languages
English (en)
Inventor
Eric Charles Reynolds
Nada Slakeski
Anne Hendtlass
Original Assignee
Univ Melbourne
Victorian Dairy Ind
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Melbourne, Victorian Dairy Ind filed Critical Univ Melbourne
Publication of ZA972757B publication Critical patent/ZA972757B/xx

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56911—Bacteria
    • G01N33/56955—Bacteria involved in periodontal diseases
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q11/00—Preparations for care of the teeth, of the oral cavity or of dentures; Dentifrices, e.g. toothpastes; Mouth rinses
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/12—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from bacteria
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/12—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from bacteria
    • C07K16/1203—Gram-negative bacteria
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/30—Immunoglobulins specific features characterized by aspects of specificity or valency
    • C07K2317/34—Identification of a linear epitope shorter than 20 amino acid residues or of a conformational epitope defined by amino acid residues
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/195—Assays involving biological materials from specific organisms or of a specific nature from bacteria

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Biomedical Technology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Urology & Nephrology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Hematology (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Virology (AREA)
  • General Physics & Mathematics (AREA)
  • Cell Biology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Food Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Pathology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Birds (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oral & Maxillofacial Surgery (AREA)
ZA9702757A 1996-03-29 1997-04-01 Porphyromonas gingivalis antigents for the diagnosis and treatment of periodontitis. ZA972757B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
AUPN9012A AUPN901296A0 (en) 1996-03-29 1996-03-29 Porphyromonas gingivalis antigens for the diagnosis and treatment of periodontitis

Publications (1)

Publication Number Publication Date
ZA972757B true ZA972757B (en) 1998-01-30

Family

ID=3793326

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA9702757A ZA972757B (en) 1996-03-29 1997-04-01 Porphyromonas gingivalis antigents for the diagnosis and treatment of periodontitis.

Country Status (12)

Country Link
US (1) US6528038B1 (de)
EP (1) EP0954529B1 (de)
JP (1) JP4358909B2 (de)
KR (1) KR100527070B1 (de)
AT (1) ATE398137T1 (de)
AU (1) AUPN901296A0 (de)
CA (1) CA2249746C (de)
DE (1) DE69738770D1 (de)
DK (1) DK0954529T3 (de)
NZ (1) NZ331557A (de)
WO (1) WO1997036923A1 (de)
ZA (1) ZA972757B (de)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AUPO652897A0 (en) 1997-04-30 1997-05-29 University Of Melbourne, The Synthetic peptide constructs for the diagnosis and treatment of periodontitis
US8129500B2 (en) * 1997-12-10 2012-03-06 Csl Limited Porphyromonas gingivalis polypeptides and nucleotides
JP2001526035A (ja) * 1997-12-10 2001-12-18 シーエスエル、リミテッド Ｐｏｒｐｈｏｒｙｍｏｎａｓｇｉｎｇｉｖａｌｉｓポリペプチドおよびヌクレオチド
AUPP494798A0 (en) 1998-07-29 1998-08-20 Pacific Biolink Pty Limited Protective protein formulation
AUPP893999A0 (en) * 1999-03-01 1999-03-25 Csl Limited Synthetic peptides containing protective epitopes for the treatment and prevention of periodontitis associated with porphyromonas gingivalis
WO2001097838A2 (en) * 2000-06-16 2001-12-27 Baylor Research Institute Adjuvants and processes to induce a specific type of immune response
JP5469785B2 (ja) * 2004-02-06 2014-04-16 有限会社 ミクロデント ポルフィロモナスジンジバリス試薬
WO2006084129A2 (en) * 2005-02-01 2006-08-10 University Of Florida Research Foundation Genes of porphyromonas gingivalis w83 involved in invasion of human cells
WO2008000028A1 (en) * 2006-06-27 2008-01-03 Oral Health Australia Pty Ltd Porphyromonas gingivalis polypeptides useful in the prevention of periodontal disease
NZ595252A (en) * 2007-07-12 2013-11-29 Oral Health Australia Pty Ltd Biofilm treatment
CN102652831A (zh) 2007-07-12 2012-09-05 口腔健康澳洲私人有限公司 生物膜的免疫治疗
CA2735171C (en) * 2008-08-29 2023-10-03 Oral Health Australia Pty Ltd Prevention, treatment and diagnosis of p.gingivalis infection
RU2012107993A (ru) * 2009-08-02 2013-09-10 Санофи Пастер Лимитид Полипептиды porhyromonas gingivalis
US8140041B2 (en) * 2009-08-27 2012-03-20 Mediatek Inc. Tunable capacitive device with linearization technique employed therein
KR102037969B1 (ko) * 2019-07-25 2019-10-29 주식회사 하이센스바이오 신규한 펩타이드
CN120157758B (zh) * 2025-03-26 2025-12-05 河南大学 牙龈卟啉单胞菌FimA单克隆抗体及其应用

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS60142915A (ja) * 1983-12-28 1985-07-29 Lion Corp 口腔用組成物
CA1282691C (en) * 1986-02-26 1991-04-09 Robert Joseph Genco Monoclonal antibodies useful in the identification of microorganisms causing periodontal disease
US5830710A (en) * 1988-09-08 1998-11-03 University Of Florida Cloned porphyromonas gingivalis genes and probes for the detection of periodontal disease
US5399484A (en) 1991-10-08 1995-03-21 Eastman Kodak Company Use of blocking protein with high pH extraction in method to determine a microorganism associated with periodontal disease and kit useful therefor
US5523390A (en) * 1993-09-10 1996-06-04 University Of Georgia Research Foundation, Inc. Porphyromonas gingivalis arginine-specific proteinase
JPH0797395A (ja) * 1993-09-28 1995-04-11 Kyowa Medex Co Ltd ポルフイロモナス・ジンジバリス線毛蛋白質の配列を含有するペプチド類及びその用途
WO1995010612A1 (en) * 1993-10-08 1995-04-20 Lion Corporation FIMBRILLIN PROTEIN OF $i(PORPHYROMONAS GINGIVALIS)
EP0753577B1 (de) * 1994-03-29 2002-07-24 Kyowa Hakko Kogyo Co., Ltd. Gen eines zelloberflächenpolypeptids

Also Published As

Publication number Publication date
DK0954529T3 (da) 2008-09-29
EP0954529A4 (de) 2003-02-05
EP0954529B1 (de) 2008-06-11
ATE398137T1 (de) 2008-07-15
NZ331557A (en) 1999-11-29
KR100527070B1 (ko) 2006-06-29
DE69738770D1 (de) 2008-07-24
CA2249746C (en) 2012-06-12
WO1997036923A1 (en) 1997-10-09
CA2249746A1 (en) 1997-10-09
AUPN901296A0 (en) 1996-04-26
KR19990087436A (ko) 1999-12-27
JP2001501808A (ja) 2001-02-13
EP0954529A1 (de) 1999-11-10
JP4358909B2 (ja) 2009-11-04
US6528038B1 (en) 2003-03-04

Similar Documents

Publication Publication Date Title
ZA972757B (en) Porphyromonas gingivalis antigents for the diagnosis and treatment of periodontitis.
AU7609687A (en) Agents for the treatment of arthroses
AU4005295A (en) Compositions for the delivery of antigens
MY134811A (en) A vaccine composition comprising an antigen, a saponin and a sterol
PL332742A1 (en) Transformed human antibody against hm 1.24
EP0536275A4 (en) Tissue-derived tumor growth inhibitors, methods of preparation and uses thereof
ATE163195T1 (de) Lösliche liganden für cd40
EP0362279A4 (de) Saponin-hilfsmittel.
GR3023233T3 (en) Inhibitors of dipeptidyl-aminopeptidase type iv
WO1995013297A3 (en) Improved immunogenic compositions against human gastrin 17
PL317536A1 (en) Monoclonal antibody against cd 44v6
HUT63063A (en) Process for producing antibodies against cd44 cell surface glycoprotein and immunosuppressant pharmaceutical compositions comprising same
CA2288234A1 (en) Synthetic peptide constructs for the diagnosis and treatment of periodontitis associated with porphyromonas gingivalis
SG48816A1 (en) Gonococcal anti-idiotypic antibodies and methods and compositions using them
ZA835951B (en) Novel polypeptide having an action on the immunological system,processes for its isolation and purification,its use,agents containing this compound,and its cleavage products,their use and agents containing these products
GB9501826D0 (en) Polypeptide fragments
EP0770624A3 (de) Peptid das eine Immunantwort gegen menschlichen Magenkrebs induziert und Arzneimittel die es enthält zur Vorbeugung oder Behandlung von Magenkrebs
CA2137280A1 (fr) Clonage du gene codant pour la proteine gp28.5 de toxoplasma gondii; fragments peptidiques de cette proteine et leurs applications
JPS5296729A (en) Mixed vaccin for cyanomycosis
WO1997039029A3 (en) An antigenic epitope of the a determinant of hepatitis b surface antigen and uses thereof
DE69535059D1 (en) Borrelia burgdorferi bacterin
IL117151A0 (en) Novel antigen
AU560165B2 (en) Chromophoric peptides
DE3560262D1 (en) Hexapeptide, process for its preparation and pharmaceutical compositions thereof
CA2038030A1 (en) Synthetic peptides which contain sequences from factor viia, and the use thereof